PDCD1 and neoplasm: PD-1 ligands PD-L1 and PD-L2 expressed in tumor cells bind to PD-1 expressed on the surface of T cells, leading to inhibitory checkpoint signaling that reduces cytotoxicity and T-cell exhaustion (56).